DE69610316T2 - Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste - Google Patents

Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste

Info

Publication number
DE69610316T2
DE69610316T2 DE69610316T DE69610316T DE69610316T2 DE 69610316 T2 DE69610316 T2 DE 69610316T2 DE 69610316 T DE69610316 T DE 69610316T DE 69610316 T DE69610316 T DE 69610316T DE 69610316 T2 DE69610316 T2 DE 69610316T2
Authority
DE
Germany
Prior art keywords
piperazine derivatives
ht1a antagonists
ht1a
antagonists
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69610316T
Other languages
English (en)
Other versions
DE69610316D1 (de
Inventor
Andrew Fensome
Gerard Kelly
Langham Mansell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of DE69610316D1 publication Critical patent/DE69610316D1/de
Application granted granted Critical
Publication of DE69610316T2 publication Critical patent/DE69610316T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69610316T 1995-07-20 1996-07-19 Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste Expired - Lifetime DE69610316T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514901.9A GB9514901D0 (en) 1995-07-20 1995-07-20 Piperazine derivatives
PCT/GB1996/001714 WO1997003982A1 (en) 1995-07-20 1996-07-19 Piperazine derivatives and their use as 5-ht1a antagonists

Publications (2)

Publication Number Publication Date
DE69610316D1 DE69610316D1 (de) 2000-10-19
DE69610316T2 true DE69610316T2 (de) 2001-03-29

Family

ID=10778004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69610316T Expired - Lifetime DE69610316T2 (de) 1995-07-20 1996-07-19 Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste

Country Status (21)

Country Link
EP (1) EP0839146B1 (de)
JP (1) JP4166824B2 (de)
KR (1) KR100447002B1 (de)
CN (2) CN1077889C (de)
AR (1) AR003451A1 (de)
AT (1) ATE196294T1 (de)
AU (1) AU700546B2 (de)
BR (1) BR9609694A (de)
CA (1) CA2227386C (de)
DE (1) DE69610316T2 (de)
DK (1) DK0839146T3 (de)
ES (1) ES2150684T3 (de)
GB (1) GB9514901D0 (de)
GR (1) GR3034408T3 (de)
HU (1) HUP9802447A3 (de)
IL (1) IL122981A (de)
MX (1) MX9800483A (de)
NZ (1) NZ313231A (de)
PT (1) PT839146E (de)
WO (1) WO1997003982A1 (de)
ZA (1) ZA966048B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
US6469007B2 (en) * 2000-11-28 2002-10-22 Wyeth Serotonergic agents
US20060223824A1 (en) 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
RU2315044C2 (ru) 2002-03-12 2008-01-20 Уайт Способ получения хиральных 1,4-дизамещенных пиперазинов
KR20040091720A (ko) * 2002-03-12 2004-10-28 와이어쓰 Ｎ1-(2'-피리딜)-1,2-프로판디아민 설팜산의 제조방법 및생물학적 활성 피페라진 합성시의 이의 용도
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
MXPA04008729A (es) * 2002-03-12 2005-07-13 Wyeth Corp Proceso para sintetizacion de piperazinas n-arilicas quirales.
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
BRPI0611948A2 (pt) 2005-06-17 2010-10-13 Wyeth Corp compostos úteis como inibidores de serotonina e agonistas de antagonista de 5-ht1a
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
CL2008000119A1 (es) 2007-01-16 2008-05-16 Wyeth Corp Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
DK0763024T3 (da) * 1994-06-03 2002-12-02 Wyeth John & Brother Ltd Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater

Also Published As

Publication number Publication date
HUP9802447A3 (en) 1999-11-29
JP4166824B2 (ja) 2008-10-15
HUP9802447A2 (hu) 1999-08-30
ZA966048B (en) 1998-01-16
CA2227386A1 (en) 1997-02-06
ATE196294T1 (de) 2000-09-15
NZ313231A (en) 2001-03-30
KR100447002B1 (ko) 2004-12-04
IL122981A (en) 2001-01-28
EP0839146B1 (de) 2000-09-13
IL122981A0 (en) 1998-08-16
GR3034408T3 (en) 2000-12-29
JPH11509544A (ja) 1999-08-24
GB9514901D0 (en) 1995-09-20
AU700546B2 (en) 1999-01-07
DE69610316D1 (de) 2000-10-19
WO1997003982A1 (en) 1997-02-06
KR19990029067A (ko) 1999-04-15
PT839146E (pt) 2000-12-29
MX9800483A (es) 1998-04-30
CN1131861C (zh) 2003-12-24
EP0839146A1 (de) 1998-05-06
BR9609694A (pt) 1999-03-23
AR003451A1 (es) 1998-08-05
CN1190968A (zh) 1998-08-19
CN1309127A (zh) 2001-08-22
ES2150684T3 (es) 2000-12-01
AU6524996A (en) 1997-02-18
CA2227386C (en) 2006-05-16
CN1077889C (zh) 2002-01-16
DK0839146T3 (da) 2000-11-20

Similar Documents

Publication Publication Date Title
DE69332898D1 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
DE69509765D1 (de) N-heterocyclyl sulphonamid-derivate und ihre verwendung als endothelin-antagonisten
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
ATA38799A (de) 1-alkoxypolyalkylpiperidinderivate und ihre verwendung als polymerisationsregler
DE59611304D1 (de) Pyrazol-4-yl-benzoylderivate und ihre verwendung als herbizide
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
ATE299503T1 (de) Pyridin-3-carbonsäurederivate und ihre verwendung als zwischenprodukte
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE69615025T2 (de) Benzamid-derivate und deren verwendung als vasopressin-antagonisten
DE69610316D1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DE69510228D1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE69613805T2 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69708629D1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
ATE260258T1 (de) Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva
DE69408674T2 (de) Phenylpyrrol-derivate und ihre verwendung als dopamin d3 antagonisten
ATE210660T1 (de) Pyrazol-4-yl-benzoylderivate und ihre verwendung als herbizide
DE69024524T2 (de) Substituierte Tetrahydroindanderivate und ihre Verwendung als Zwischenprodukte
DE60008539D1 (de) Substituierte isochinolinderivate und ihre verwendung als anticonvulsiva
DE69412083D1 (de) Phenylpyrrolderivate und ihre verwendung als antipsychotika
DE59610382D1 (de) Halogenbenzimidazole und ihre verwendung als mikrobizide
DE69718850D1 (de) Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide
DE69607578T2 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69707602T2 (de) Substituierte Vinylharnstoff-Derivate und ihre Verwendung als ACAT-Inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH (N.D.GES.D. STAATES DELAWARE), MADISON, N.J.